The largest database of trusted experimental protocols

Atp flaas

Manufactured by Merck Group
Sourced in Germany

ATP (FLAAS) is a laboratory instrument designed for the detection and quantification of adenosine triphosphate (ATP). It functions as a bioluminescent assay system that measures the light emitted during the ATP-dependent oxidation of luciferin by the luciferase enzyme. The core function of this product is to provide a reliable and sensitive method for the detection and measurement of ATP levels in various samples.

Automatically generated - may contain errors

2 protocols using atp flaas

1

In vitro and in vivo ubiquitination assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo ubiquitination assay, HEK-293T cells were co-transfected with indicated expressing plasmids. Cells were grown overnight and were then treated with MG132 (10 μM) for 6 h, followed by immunoprecipitation and western blot analyses.
In vitro ubiquitination assay was performed as essentially described [35 (link)]. Briefly, HEK-293T cells were co-transfected with indicated expressing plasmids. Moreover, 36 h post-transfection, cells were treated with MG132 (10 μM) for 6 h before immunoprecipitation with anti-HA beads. Purified FBXO3 on HA-beads were added to the in vitro ubiquitylation mixture containing 50 mM Tris (pH 7.6), 5 mM Mgcl2, 0.6 mM DTT, 2 mM ATP (FLAAS, Sigma-Aldrich), 1.5 ng/μl E1 (UBE1, 23–021, Merck Millipore, Darmstadt, Germany), 10 ng/μl UbcH5a (23–029, Merck Millipore), 10 ng/μl UbcH7 (23–047, Merck Millipore), 1 mg/ml ubiquitin (662057, Merck Millipore), and 1 μM ubiquitin aldehyde (662056, Merck Millipore). Samples were incubated for 2 h at 30°C and subjected to western blot analysis.
+ Open protocol
+ Expand
2

In vivo and in vitro EGFR ubiquitination

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo ubiquitination assay, HEK293T cells were co-transfected with expressing plasmids encoding Flag-EGFR, FBXL2, and either wild-type HA-ubiquitin, HA-ubiquitin-Lys 48-only or HA-ubiquitin-Lys 63-only. Cells were grown overnight and were then treated with 20 μM MG132 for 4 h before harvesting. Cell lysates were immunoprecipitated using anti-Flag resin, followed by Western blot analyses.
In vitro ubiquitination assay was performed as described28 (link). Briefly, HEK 293T cells were co-transfected with Flag-EGFR and HA-FBXL2 or HA-FBXL2∆F expressing plasmids. Thirty-six hours post transfection, cells were treated with 20 μM MG132 for 4 h before immunoprecipitation with anti-HA beads, which were then added to the in vitro ubiquitylation mixture containing 0.1 μM E1 (UBE1, 23-021, Merck Millipore), 0.25 μM Ubch3 (23-022, Merck Millipore), 0.25 μM Ubch5c (23-035, Merck Millipore), 2 mM ATP (FLAAS, Sigma-Aldrich) in the presence or absence of 1 μM ubiquitin aldehyde (Millipore, 662056) and 2.5 μg/μL ubiquitin (Millipore, 662057). Samples were incubated for 2 h at 30 °C and analyzed by immunoblotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!